Switzerland · Series B startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 2 rounds since 2019, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Pureos BioventuresLead
Wings for LifeReported by Firms' own news pages and 2 others
From NovaGo Therapeutics's own website: 5 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
NovaGo Therapeutics's investors include Pureos Bioventures, Neurimmune, Pureos, BioVenture and Swiss Paraplegic Foundation, and 2 more on record. Pureos Bioventures led its latest round.
NovaGo Therapeutics has raised $40M across 2 rounds since 2019.
NovaGo Therapeutics's most recent round was a Series B of $30M in Sept 2026, led by Pureos Bioventures.
Its most recent round, $30M in Sept 2026, is also its largest on record.
NovaGo Therapeutics's first round on record, in Mar 2019, was backed by Pureos Bioventures, BioVenture and Neurimmune.
NovaGo Therapeutics's latest named round is a Series B, in Sept 2026.
NovaGo Therapeutics is based in Switzerland.
Pureos Bioventures led the Series A in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland · 
